AIM
AIM ImmunoTech
33 hedge funds and large institutions have $1.86M invested in AIM ImmunoTech in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
33
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$15K | |
| 2 | +$7.92K | |
| 3 | +$6.69K | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$6.16K |
| 5 |
Renaissance Technologies
New York
|
+$4.27K |
Top Sellers
| 1 | -$43K | |
| 2 | -$27.6K | |
| 3 | -$6.06K | |
| 4 |
HF
HRT Financial
New York
|
-$4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.58K |